Integra LifeSciences IART Short-term borrowings under securitization facility

Short-term borrowings under securitization facility at other companies

Aveanna Healthcare Holdings Inc.AVAH

$165M-2.2%

Intercontinental ExchangeICE

$1.75B-40.3%

PPG IndustriesPPG

$41M+215%

Henry ScheinHSIC

$1.05B+20.6%

ChevronCVX

$5.83B+43.0%

Philip Morris InternationalPM

$5.69B+28.3%

Other financials

Income statement

See full

Revenue$391.9M+2.4%

Gross profit$217.0M+11.6%

Operating income$11.5M+174%

Net income-$4.6M+81.7%

EPS (diluted)-$0.06+81.8%

Balance sheet

See full

Cash & equivalents$236.8M-1.0%

Total debt$2.0B+3.2%

Total equity$1.0B-31.6%

Total assets$3.6B-11.7%

Cash flow

See full

Operating cash flow$9.8M+187%

CapEx$14.8M-48.7%

Free cash flow-$5.0M+87.4%

Valuation

See full

Market cap$1.38B-56.8%

Enterprise value$3.12B-26.7%

P/S0.8×-1.1×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin-29.8%-30.3pp

Net margin-30.1%—

FCF margin3.8%-6.3pp

Returns & leverage

See full

Return on equity-38.6%—

Debt / equity1.9×+0.6×

Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept iart:SecuredDebtSecuritizationProgramCurrent.

The official record: Integra LifeSciences’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's short-term borrowings under securitization facility.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Integra LifeSciences's short-term borrowings under securitization facility?: Integra LifeSciences (IART) reported short-term borrowings under securitization facility of $87.8M in Q4 2025.
What does short-term borrowings under securitization facility mean?: This represents the short-term portion of debt obligations financed through a securitization facility, where specific assets are pledged as collateral. It reflects the company's reliance on asset-backed financing to manage working capital and short-term funding needs. Investors track this to understand the company's dependency on specialized credit facilities and the potential impact of asset performance on liquidity.